The effect of riboflavin on the hematologic changes in iron supplementation of schoolchildren.

dc.contributor.authorCharoenlarp, Pen_US
dc.contributor.authorPholpothi, Ten_US
dc.contributor.authorChatpunyaporn, Pen_US
dc.contributor.authorSchelp, F Pen_US
dc.date.accessioned2009-05-27T14:56:04Z
dc.date.available2009-05-27T14:56:04Z
dc.date.issued1980-03-01en_US
dc.descriptionThe Southeast Asian Journal of Tropical Medicine and Public Health.en_US
dc.description.abstractA supplementation trial was carried out in 101 children, 6-12 years of age, in 3 primary schools in a rural area. Their hemoglobin level and PCV (mean +/- SD) were 11.64 +/- 1.21 g/dl and 0.356 +/- 0.028 respectively, 74% of them were anemic and the hemoglobin level were correlated with the MCHC (P < .01) . Fifty-one per cent of them had hookworm infection and all those with hemoglobin levels below 10 g/dl had hookworm infection, but there was no difference in mean hemoglobin level between those with hookworm infection and those without. The children were divided into 3 groups: Group I comprising 39 children who received placebo tablest; Group II of 33, who received ferrous sulphate (60 mg elemental iron); Group III of 29, who received ferrous sulphate (60 mg elemental iron) with riboflavin (6mg). Each child received one tablet after lunch on schooldays and evaluation was carried out after receiving 80 to 90 tablets. The mean hemoglobin change of Group II was 0.60 g/dl larger than that of Group I (P < .005) with 52% of them responding to iron. The mean hemoglobin change of Group III was 0.38 g/dl larger than that of Group II (P < .005) with 86% of them responding to iron and riboflavin. Thus additional riboflavin is beneficial in iron supplementation.en_US
dc.identifier.citationCharoenlarp P, Pholpothi T, Chatpunyaporn P, Schelp FP. The effect of riboflavin on the hematologic changes in iron supplementation of schoolchildren. The Southeast Asian Journal of Tropical Medicine and Public Health. 1980 Mar; 11(1): 97-103en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/31476
dc.language.isoengen_US
dc.source.urihttps://www.tm.mahidol.ac.th/seameo/publication.htmen_US
dc.subject.meshChilden_US
dc.subject.meshClinical Trials as Topicen_US
dc.subject.meshFemaleen_US
dc.subject.meshFerrous Compounds --pharmacologyen_US
dc.subject.meshHematocriten_US
dc.subject.meshHemoglobins --metabolismen_US
dc.subject.meshHookworm Infections --blooden_US
dc.subject.meshHumansen_US
dc.subject.meshIron --pharmacologyen_US
dc.subject.meshMaleen_US
dc.subject.meshMebendazole --therapeutic useen_US
dc.subject.meshPlacebosen_US
dc.subject.meshRiboflavin --pharmacologyen_US
dc.subject.meshRural Populationen_US
dc.subject.meshThailanden_US
dc.titleThe effect of riboflavin on the hematologic changes in iron supplementation of schoolchildren.en_US
dc.typeClinical Trialen_US
dc.typeComparative Studyen_US
dc.typeControlled Clinical Trialen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: